Retatrutide (LY-3437943) – 40 MG
Retatrutide, also known as LY-3437943, is a cutting-edge triple-hormone receptor agonist that engages glucagon, GLP-1, and GIP receptors. It’s revolutionizing metabolic research by delivering potent, sustained weight and glycemic control—shown in trials to yield up to ~24% weight loss at higher doses. Ideal for advanced obesity and endocrine pathway studies.
Note: Not for human or veterinary use. For in-vitro research only.
For assistance, visit our Contact page or use live chat.
Retatrutide (LY-3437943) – 40 MG
Retatrutide, also known as LY-3437943, is a cutting-edge triple-hormone receptor agonist that engages glucagon, GLP-1, and GIP receptors. It’s revolutionizing metabolic research by delivering potent, sustained weight and glycemic control—shown in trials to yield up to ~24% weight loss at higher doses. Ideal for advanced obesity and endocrine pathway studies.
Note: Not for human or veterinary use. For in-vitro research only.
For assistance, visit our Contact page or use live chat.
Regulatory & Use
For laboratory research only. Not for human or veterinary use.